A randomised controlled trial to assess the safety, acceptability and pharmacokinetics of a sustained-release tenofovir-alafenamide sub-dermal implant for HIV prevention in women

Abdool Karim, Salim (PI)

Mailman School of Public Health

Projet

Statut	Terminé
Date de début/de fin réelle	1/1/17 → 12/31/19

Financement

European and Developing Countries Clinical Trials Partnership: 22 392 332,00 $ US

Keywords

Dermatología
Salud pública, medioambiental y laboral
Farmacología
Enfermedades infecciosas